EVARREST™ Fibrin Sealant Patch

BIOLOGICAL2 trials

Sponsors

Ethicon, Inc.

Conditions

Cardiovascular DiseaseHemorrhageSoft Tissue Bleeding

Phase 3

The Fibrin Pad CV Phase III Study

CompletedNCT02040428

Ethicon, Inc.Cardiovascular Disease

Start: 2014-01-01End: 2015-09-01Updated: 2017-08-15

Phase 4

EVARREST™ Fibrin Sealant Patch Post-Market Study

CompletedNCT01902459

Ethicon, Inc.Hemorrhage, Soft Tissue Bleeding

Start: 2013-07-01End: 2015-09-01Updated: 2018-01-17